Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Vaccine|February 17, 2006
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvantBertrand Bellier, Charlotte Dalba, Béatrice Clerc, et al.Journal of Virology|August 11, 2017
Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor ActivationFabien Pitoiset, Thomas Vazquez, Beatrice Levacher, et al.JCI Insight|October 5, 2016
TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapiesTristan Courau, Djamel Nehar-Belaid, Laura Florez, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2016
Low-Dose IL-2 Induces Regulatory T Cell-Mediated Control of Experimental Food AllergyBenjamin Bonnet, James Vigneron, Béatrice Levacher, et al.The Journal of Gene Medicine|February 28, 2009
Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine developmentDelphine Desjardins, Christophe Huret, Charlotte Dalba, et al.Human Gene Therapy|March 26, 2013
Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancersGeraldine Lescaille, Fabien Pitoiset, Rodney Macedo, et al.Avian Diseases|June 5, 2010
Identification of a dominant epitope in the hemagglutinin of an Asian highly pathogenic avian influenza H5N1 clade 1 virus by selection of escape mutantsHelena Lage Ferreira, Bénédicte Lambrecht, Steven van Borm, et al.Plos Computational Biology|March 22, 2016
Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell ResponsesNicolas Dérian, Bertrand Bellier, Hang Phuong Pham, et al.Vaccine|August 7, 2009
DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodiesBertrand Bellier, Christophe Huret, Mathilde Miyalou, et al.Nature Aging|June 5, 2024
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's diseaseMarie Sarazin, Julien Lagarde, Inès El Haddad, et al.Pageof 4